Statistics

Total Visits

Views
Cost-effectiveness of atezolizumab versus pembrolizumab as first-line treatment in PD-L1-positive advanced non-small-cell lung cancer in Spain20

File Visits

Downloads
763.pdf14

Select a period of time:

Number of views in the range

Views
Cost-effectiveness of atezolizumab versus pembrolizumab as first-line treatment in PD-L1-positive advanced non-small-cell lung cancer in Spain20

Number of downloads in the range

Downloads
763.pdf14

Views

Views
September 20253
October 20252
November 20251
December 20250
January 20261
February 20260
March 202613
Download CSV file
 untranslated
 untranslated

Number of downloads in the period of time

  • Downloads
  • September 2025
    0
  • October 2025
    4
  • November 2025
    0
  • December 2025
    1
  • January 2026
    2
  • February 2026
    0
  • March 2026
    7
  • Download CSV file
 untranslated
 untranslated

Top country views

Views
United States9
Brazil4
Argentina2
Ecuador1
Finland1
Mexico1
Poland1
Portugal1
 

Top countries by downloads

Downloads
United States3
Ecuador1
Mexico1
 

Top cities views

Views
Katowice1
Laranjal Paulista1
Nova Londrina1
Nova Timboteua1
Tijuana1
Tunuyán1
Uberaba1
 

Top cities by downloads

Downloads